54 /100
HIGH RISK
Score updated Jul 14, 2026

NSRX — Nasus Pharma Ltd. Dilution Risk Tracker

Track NSRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NSRX — Get alerts when the score changes →

As of July 14, 2026, Nasus Pharma Ltd. (NSRX) has a DilutionWatch DilutionScore of 54/100, rated HIGH dilution risk. Nasus Pharma Ltd. has a market capitalization of $39.35M, 9.02M shares outstanding, 9 institutional holders tracked. Key dilution vectors include approximately 3 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
85
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄Convertible Debt—

🌦️ Dilution Forecast

⛅
Watch
Minor dilution signals detected
22%
💰 Capital Raise 35%
• Low cash runway: 3 months remaining
🔄 Reverse Split 15%
• Only 3 months cash — financial pressure
🔔 Track NSRX — Get forecast alerts →

💹 Market Data

Market Cap$39.35M
Shares Outstanding9.02M
Float4.86M
Cash$1.24M
Debt$118.0K
Short InterestN/A

🏛 Institutional Holdings

9 institutional holders · 2.18M shares
#1 Balyasny Asset Management L.P. 898.5K shares
#2 Cable Car Capital, LP 602.0K shares
#3 Velan Capital Investment Management LP 359.4K shares
+ 6 more holders Sign up free to view →

📉 Short Interest

Short Interest172.1K
Days to Cover6.9
% of Float3.5%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for NSRX Shareholders

Nasus Pharma Ltd. (NSRX) has a DilutionScore of 54/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: NSRX has approximately 3 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for NSRX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for NSRX alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track NSRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NSRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

AGMH ALLR AMSS APC APRE

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for NSRX
📊 NSRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NSRX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.